EP.12H.09 Phase 1b/2a Study of ATR Inhibitor Tuvusertib + Anti-PD-1 Cemiplimab in Patients with Advanced Non-Squamous NSCLC

Autor: Vokes, N., Paz-Ares, L., Cappuzzo, F., Yamamoto, N., Gray, J.E., Owonikoko, T., Ariyasu, R., Ishii, H., Kang, J.H., Lee, S.-H., Hallwachs, R., Coenen-Stass, A., Sarholz, B., Pudelko, L., Kaur Mukker, J., Moulin, C., Gounaris, I., Villaruz, L.C.
Zdroj: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S660-S660
Databáze: ScienceDirect